Global Edition
REF: 685
Insight

CEO reveals Moderna's interest in German production amid BioNTech facility shutdowns.

Moderna's CEO, Stephane Bancel, has expressed interest in establishing manufacturing sites in Germany, specifically targeting facilities slated for closure by its domestic competitor BioNTech.

Insight — lead image
Lead image — News Trend Today wire

Moderna's CEO, Stephane Bancel, has expressed interest in establishing manufacturing sites in Germany, specifically targeting facilities slated for closure by its domestic competitor BioNTech.

Moderna, a leading US pharmaceutical firm (MRNA.O), is exploring investment opportunities in German production facilities, particularly those slated for closure by its German competitor BioNTech, according to CEO Stephane Bancel's remarks to Handelsblatt on Wednesday.

RelatedPrince George set for esteemed education at Eton.

Moderna's CEO considers partnering with Germany as a viable alternative to constructing new facilities, given the right collaboration with local authorities.

Moderna, a leading US pharmaceutical firm (MRNA.O),is exploring investment opportunities in German production facilities, particularly those slated for closure by its German competitor BioNTech, according to CEO Stephane Bancel's remarks to Handelsblatt on Wednesday.

Read nextAlgae infestation prompts emergency response at Reflecting Pool.

More Filings

Insight
Insight

Prince George set for esteemed education at Eton.

Insight
Insight

Algae infestation prompts emergency response at Reflecting Pool.

Insight
Insight

Telehealth firms receive 25 warning letters from the US FDA regarding weight-loss medication claims.